Tech Company Financing Transactions
Satiogen Pharmaceuticals Funding Round
Private investors participated in a $700 thousand capital raise for Satiogen Pharmaceuticals. This venture round was announced on 2/7/2008.
Transaction Overview
Company Name
Announced On
2/7/2008
Transaction Type
Venture Equity
Amount
$700,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
350 10th Ave. 820
San Diego, CA 92101
USA
San Diego, CA 92101
USA
Phone
Website
Email Address
Overview
The company is developing weight loss pharmaceuticals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Ted Greene
Chief Executive Officer
Robert Ayling
Co-Founder
Bronislava Gedulin
Co-Founder
Andrew Young
Browse more venture capital transactions:
Prev: 2/7/2008: Dizzywood venture capital transaction
Next: 2/7/2008: Cellfire venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs